CompletedPhase 2

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

United States32 participantsStarted 2011-08

Plain-language summary

This pilot trial studies the differentiation of bone sarcomas and osteomyelitis with ferumoxytol-enhanced magnetic resonance imaging (MRI). Imaging procedures that allow doctors to more accurately differentiate between malignant bone sarcomas and osteomyelitis may help in diagnosing patients correctly and may result in more timely treatment.

Who can participate

Age range

10 Years – 21 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

INCLUSION CRITERIA * Age 10 to 21 years * Suspected or confirmed diagnosis of a bone sarcoma or osteomyelitis * Informed consent with assent as appropriate. EXCLUSION CRITERIA * Contraindication to MRI * Presence of metal implants * Need for sedation or anesthesia * Claustrophobia * Hemosiderosis or hemochromatosis * History of allergic reactions to similar compounds will be obtained and patients with positive history of allergic reactions will be excluded from the study * Females who are pregnancy or nursing

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

T2* Relaxation Time of Bone Sarcomas and Osteomyelitis Subjects

Timeframe: 24 hours

Trial details

NCT IDNCT01336803

SponsorHeike E Daldrup-Link

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-07

Results submitted2019-05-03

View on ClinicalTrials.gov More Bone Cancer trials